RNA Formulation Solutions

  1. Systems For Lipid Nanoparticle (LNP) Production 12/6/2024

    Delve into the world of lipid nanoparticle (LNP) production and formulation, exploring cutting-edge technologies and applications in targeted drug delivery.

  2. Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation 7/13/2023

    LipidBrick® IM21.7c

    •  Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
    •  Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
    •  Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
  3. GenVoy-ILM™: Power To Explore 4/14/2022

    GenVoy-ILM is a pre-optimized lipid mixture designed to encapsulate RNA – mRNA, gRNA, siRNA, miRNA, tRNA – in LNP.

  4. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

  5. New Solutions For Large Molecule Analysis 6/16/2023

    Explore Biozen LC Portfolio

    With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:

    • Charge Variant Analysis
    • Aggregate Analysis
    • Peptide Mapping
    • Intact Mass Intact and Fragment Analysis
    • Glycan Analysis
    • Peptide Quantitation
    • Drug Antibody Ratio (DAR)
    • Oligonucleotide Characterization
  6. mRNA/LNP Development And Manufacturing Services

    Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.

  7. Metabolite And Lipid Analysis Service 10/29/2024

    Unlock actionable insights into your cell culture process with metabolite and lipid analysis, enabling data-driven optimizations for growth, titer, and product quality.

  8. CD34+ HSC LNP Kits 4/24/2025

    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  9. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

  10. Put Your Oligo Synthesis In Good Hands 1/27/2026

    Explore how smart column design supports consistent, high‑yield oligonucleotide synthesis, which formats fit development, and how optimized features help improve efficiency and safety.